Verastem Inc (VSTM)
9.375
+0.16
(+1.74%)
USD |
NASDAQ |
Apr 26, 10:19
Verastem Price to Book Value: 4.135 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 4.065 |
| April 24, 2024 | 4.107 |
| April 23, 2024 | 4.239 |
| April 22, 2024 | 4.296 |
| April 19, 2024 | 4.340 |
| April 18, 2024 | 4.512 |
| April 17, 2024 | 4.782 |
| April 16, 2024 | 4.821 |
| April 15, 2024 | 4.883 |
| April 12, 2024 | 4.984 |
| April 11, 2024 | 5.209 |
| April 10, 2024 | 4.984 |
| April 09, 2024 | 5.178 |
| April 08, 2024 | 5.232 |
| April 05, 2024 | 5.046 |
| April 04, 2024 | 4.998 |
| April 03, 2024 | 5.284 |
| April 02, 2024 | 5.082 |
| April 01, 2024 | 5.174 |
| March 28, 2024 | 5.205 |
| March 27, 2024 | 5.214 |
| March 26, 2024 | 5.112 |
| March 25, 2024 | 5.083 |
| March 22, 2024 | 5.308 |
| March 21, 2024 | 5.260 |
| Date | Value |
|---|---|
| March 20, 2024 | 5.198 |
| March 19, 2024 | 4.986 |
| March 18, 2024 | 4.682 |
| March 15, 2024 | 4.850 |
| March 14, 2024 | 4.629 |
| March 13, 2024 | 4.735 |
| March 12, 2024 | 4.776 |
| March 11, 2024 | 5.041 |
| March 08, 2024 | 5.098 |
| March 07, 2024 | 5.195 |
| March 06, 2024 | 5.592 |
| March 05, 2024 | 5.464 |
| March 04, 2024 | 5.592 |
| March 01, 2024 | 5.737 |
| February 29, 2024 | 5.490 |
| February 28, 2024 | 5.645 |
| February 27, 2024 | 5.781 |
| February 26, 2024 | 5.768 |
| February 23, 2024 | 5.596 |
| February 22, 2024 | 5.305 |
| February 21, 2024 | 5.433 |
| February 20, 2024 | 5.583 |
| February 16, 2024 | 5.486 |
| February 15, 2024 | 5.173 |
| February 14, 2024 | 5.226 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9864
Minimum
Oct 20 2022
64.98
Maximum
Mar 06 2020
4.702
Average
3.062
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 5.130 |
| Geron Corp | 8.303 |
| Altimmune Inc | 2.674 |
| Oragenics Inc | 3.129 |
| Actinium Pharmaceuticals Inc | 5.349 |
Price to Book Value Related Metrics
| PS Ratio | 56.68 |
| PEG Ratio | -0.0367 |
| Price | 9.375 |
| Earnings Yield | -43.84% |
| Market Cap | 237.26M |
| PEGY Ratio | -0.0367 |